Engineered extracellular vesicle-delivered TGF-β inhibitor for attenuating osteoarthritis by targeting subchondral bone
Zhaopu Jing(Second Affiliated Hospital of Xi'an Jiaotong University), Xiaoqian Dang(Second Affiliated Hospital of Xi'an Jiaotong University), Guangyang Zhang(National University of Defense Technology), Yuanqing Cai(Second Affiliated Hospital of Xi'an Jiaotong University), Leifeng Lv(Second Affiliated Hospital of Xi'an Jiaotong University), Jialin Liang(Second Affiliated Hospital of Xi'an Jiaotong University)
Cited by 19
Related Papers
The Burden of Rheumatoid Arthritis: Findings from the 2019 Global Burden of Diseases Study and Forecasts for 2030 by Bayesian Age-Period-Cohort Analysis
|Journal of Clinical Medicine|2023|123
Nonlinear geometric phase coded ferroelectric nematic fluids for nonlinear soft-matter photonics
|Nature Communications|2024|65
Green synthesis of tannic acid functionalized graphene hydrogel to efficiently adsorb methylene blue
|Colloids and Surfaces A Physicochemical and Engineering Aspects|2021|63
Exosomes derived from M2 macrophages induce angiogenesis to promote wound healing
|Frontiers in Molecular Biosciences|2022|62
AoI Minimization for WSN Data Collection With Periodic Updating Scheme
|IEEE Transactions on Wireless Communications|2022|44